While the sector’s business is not expected to fully recover until the second half of the year, stock prices have risen sharply, underestimating the level of dividend yields. According to Kirill Komarov, head of the investment advisory department at Tinkoff Investments, companies in the pharmaceutical industry, as well as some […]